PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35440680-0	2022	Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection.	Mitoxantrone	0-12	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	41-46	
35440680-4	2022	Here, we show that Mitoxantrone, an FDA-approved topoisomerase inhibitor, targets a heparan sulfate-spike complex to compromise the fusogenic function of spike in viral entry.	Mitoxantrone	19-31	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	100-105	
35440680-4	2022	Here, we show that Mitoxantrone, an FDA-approved topoisomerase inhibitor, targets a heparan sulfate-spike complex to compromise the fusogenic function of spike in viral entry.	Mitoxantrone	19-31	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	154-159